Add to my selection

GHRYVELIN (acétate de macimoréline)

Medicine - Posted on Apr 12 2023

Active substance (DCI)

acétate de macimoréline

history (1)

4/5/23

GHRYVELIN (macimorelin acetate) - Diagnosis of growth hormone (GHD) deficiency

First assessment. Key points Favourable opinion on reimbursement under “this medicinal product is for diagnostic use only. G...

CAV :
54321

icône flèche

Technical information

ATC code

V04CD06

Manufacturer

CONSILIENT HEALTH LIMITED

Presentation

GHRYVELIN 60 mg, granulés pour suspension buvable en sachet
1 sachet polyéthylène basse densité (PEBD) aluminium papier de 1,817 mg (CIP : 340 095 508 64 20)

All our publications

Biology (laboratory tests)

Drug therapy

Endocrine system diseases

My account

You do not have a saved search

No element in selection

GHRYVELIN (acétate de macimoréline)

GHRYVELIN (macimorelin acetate) - Diagnosis of growth hormone (GHD) deficiency

Follow us :